Hetzer Medical Indonesia Past Earnings Performance
Past criteria checks 0/6
Hetzer Medical Indonesia's earnings have been declining at an average annual rate of -62.6%, while the Medical Equipment industry saw earnings growing at 9.2% annually. Revenues have been declining at an average rate of 16.5% per year.
Key information
-62.6%
Earnings growth rate
-62.7%
EPS growth rate
| Medical Equipment Industry Growth | 12.3% |
| Revenue growth rate | -16.5% |
| Return on equity | -0.3% |
| Net Margin | -0.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Hetzer Medical Indonesia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 23,788 | -165 | 12,785 | 0 |
| 31 Dec 23 | 22,723 | -3,570 | 15,029 | 0 |
| 30 Sep 23 | 18,326 | -9,704 | 13,280 | 0 |
| 31 Mar 23 | 28,472 | -6,825 | 17,627 | 0 |
| 31 Dec 22 | 37,737 | 237 | 16,472 | 0 |
| 30 Sep 22 | 43,995 | -3,513 | 19,849 | 0 |
| 31 Mar 22 | 63,272 | 13,017 | 19,396 | 0 |
| 31 Dec 21 | 75,790 | 26,631 | 19,914 | 0 |
| 31 Dec 20 | 87,790 | 37,962 | 9,968 | 0 |
| 31 Dec 19 | 12,022 | 308 | 2,547 | 0 |
Quality Earnings: MEDS is currently unprofitable.
Growing Profit Margin: MEDS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MEDS is unprofitable, and losses have increased over the past 5 years at a rate of 62.6% per year.
Accelerating Growth: Unable to compare MEDS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MEDS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.5%).
Return on Equity
High ROE: MEDS has a negative Return on Equity (-0.26%), as it is currently unprofitable.